The groundbreaking therapy of the medication represents a major advance in the care of diabetes mellitus type 2. Different to existing drugs, tirzepatide targets dual pathways – glucagon-like peptide-1 (GLP-1) and https://tirzepatide-peptide678209.win-blog.com/23334224/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment